Babesia bigemina, Babesia argentina, and Anaplasma marginale: Coinfectious immunity in bovines.
D000709:Anaplasma / Q000276:immunology; D000712:Anaplasmosis / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D000740:Anemia / Q000662:veterinary; D000818:Animals; D001403:Babesia / Q000276:immunology; D001404:Babesiosis / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D002224:Carbanilides / Q000627:therapeutic use; D002417:Cattle; D002418:Cattle Diseases / Q000188:drug therapy / Q000276:immunology*; D003168:Complement Fixation Tests; D006037:Glyoxal / Q000031:analogs & derivatives / Q000627:therapeutic use; D006400:Hematocrit; D007093:Imidazoles / Q000627:therapeutic use; D007273:Injections, Intramuscular; D008297:Male; D010118:Oxytetracycline / Q000627:therapeutic use; D013882:Thiosemicarbazones / Q000627:therapeutic use; D013987:Ticks / Q000469:parasitology; D014611:Vaccination / Q000662:veterinary
D002224:Carbanilides; D007093:Imidazoles; D013882:Thiosemicarbazones; D006037:Glyoxal; D010118:Oxytetracycline